# FDA Inspection 1293010 - Amgen Inc. - November 06, 2025

Source: https://www.keypedia.com/records/fda_inspections/amgen-inc/fa1bdcd1-cd95-435e-a357-cacef4563079
Source feed: FDA_Inspections

> FDA Inspection 1293010 for Amgen Inc. on November 06, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293010
- Company Name: Amgen Inc.
- Inspection Date: 2025-11-06
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1293010 - 2025-11-06](https://www.keypedia.com/records/fda_inspections/amgen-inc/36d99e51-c9e8-4159-ba2f-2c7bf540403e)
- [FDA Inspection 1234412 - 2024-07-30](https://www.keypedia.com/records/fda_inspections/amgen-inc/a9fcf4aa-8670-4e0c-9f32-453a0e3acf16)

Company: https://www.keypedia.com/companies/amgen-inc/ebaa268e-d67a-4623-8e1b-ed5f19dbbf2b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d